The estimated Net Worth of Public Equities, L.P.Invus ... is at least 9.4 百万$ dollars as of 8 December 2020. Public Invus owns over 790,000 units of Seer stock worth over 9,403,867$ and over the last 4 years Public sold SEER stock worth over 0$.
Public has made over 1 trades of the Seer stock since 2020, according to the Form 4 filled with the SEC. Most recently Public bought 790,000 units of SEER stock worth 15,010,000$ on 8 December 2020.
The largest trade Public's ever made was buying 790,000 units of Seer stock on 8 December 2020 worth over 15,010,000$. On average, Public trades about 790,000 units every 0 days since 2020. As of 8 December 2020 Public still owns at least 5,840,911 units of Seer stock.
You can see the complete history of Public Invus stock trades at the bottom of the page.
Over the last 7 years, insiders at Seer have traded over 150,878,393$ worth of Seer stock and bought 1,798,420 units worth 33,507,980$ . The most active insiders traders include Omid Farokhzad、Terrance Mcguire、Growth Fund Limited Partner.... On average, Seer executives and independent directors trade stock every 60 days with the average trade being worth of 227,813$. The most recent stock trade was executed by Dipchand Nishar on 14 June 2024, trading 12,109 units of SEER stock currently worth 21,554$.
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the secrets of the proteome. It develops Proteograph Product Suite, an integrated solution that comprises consumables, an automation instrumentation, and software that allows researchers to conduct proteomic studies in therapeutic and diagnostic research, and clinical trials. The company intends to sell its products for research purposes, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It has a collaboration agreement with Discovery Life Sciences, LLC. and the Salk Institute for Biological Studies. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Seer executives and other stock owners filed with the SEC include: